The effect of posterior and lateral approach on patient-reported outcome measures and physical function in patients with osteoarthritis, undergoing total hip replacement: a randomised controlled trial protocol [PDF]
Signe Rosenlund +4 more
openalex +1 more source
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
Voices that matter: The impact of patient-reported outcome measures on clinical decision-making. [PDF]
Jeyaraman N +4 more
europepmc +1 more source
Assessing severity of illness and outcomes of treatment in children with 
Kirstie Haywood +2 more
openalex +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Assessing Participation Among Stroke Survivors: A Systematic Review of Patient-Reported Outcome Measures. [PDF]
Hamid B +3 more
europepmc +1 more source
The Family Reported Outcome Measure (c): initial validation of a generic QoL measure for family members of patients with chronic medical conditions [Abstract] [PDF]
Catherine Jane Golics +3 more
openalex
Measurement properties of patient-reported outcome measures (PROMS) in Patellofemoral Pain Syndrome: A systematic review [PDF]
Andrew Green +3 more
openalex +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source

